Compile Data Set for Download or QSAR
Report error Found 606 of ic50 data for polymerid = 11220,49001081,49001083
TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260242(US9522914, A-44)
Affinity DataIC50: 0.160nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260242(US9522914, A-44)
Affinity DataIC50: 0.160nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260267(US9522914, B-20)
Affinity DataIC50: 0.430nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260267(US9522914, B-20)
Affinity DataIC50: 0.430nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260241(US9522914, A-43)
Affinity DataIC50: 0.490nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260241(US9522914, A-43)
Affinity DataIC50: 0.490nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260347(US9522914, D-36)
Affinity DataIC50: 0.610nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260347(US9522914, D-36)
Affinity DataIC50: 0.610nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260206(US9522914, A-08)
Affinity DataIC50: 0.820nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260206(US9522914, A-08)
Affinity DataIC50: 0.820nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260237(US9522914, A-39)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM50345056(2-(6-(3-((dimethylamino)methyl)phenyl)-2-(4-fluoro...)
Affinity DataIC50: 1nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells co-expressing VIP-luciferase by scintillation counting-based whole...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260237(US9522914, A-39)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260248(US9522914, B-01)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260264(US9522914, B-17)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260248(US9522914, B-01)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260264(US9522914, B-17)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260329(US9522914, D-18)
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260329(US9522914, D-18)
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Rat)
Msd

Curated by ChEMBL
LigandPNGBDBM50338810(N-isopropyl-2-(2-(3-methoxyphenyl)-4-oxo-6-(3-(pip...)
Affinity DataIC50: 2nMAssay Description:Displacement of [3H]AVP from rat vasopressin V1b receptor expressed in CHO cells by whole cell binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM50345045(N-isopropyl-2-(2-(3-methoxyphenyl)-4-oxo-6-(3-(pip...)
Affinity DataIC50: 2nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells co-expressing VIP-luciferase by scintillation counting-based whole...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260249(US9522914, B-02)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260256(US9522914, B-09)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260308(US9522914, C-19)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260249(US9522914, B-02)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260256(US9522914, B-09)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260308(US9522914, C-19)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260213(US9522914, A-15)
Affinity DataIC50: 2.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260213(US9522914, A-15)
Affinity DataIC50: 2.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260316(US9522914, D-05)
Affinity DataIC50: 2.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260316(US9522914, D-05)
Affinity DataIC50: 2.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM50416630(CHEMBL1223545)
Affinity DataIC50: 2.51nMAssay Description:Antagonist activity at human vasopressin 1b receptor expressed in CHO cells assessed as inhibition of vasopressin-induced intracellular calcium mobil...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260220(US9522914, A-22)
Affinity DataIC50: 2.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260220(US9522914, A-22)
Affinity DataIC50: 2.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260352(US9522914, D-41)
Affinity DataIC50: 2.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260352(US9522914, D-41)
Affinity DataIC50: 2.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260255(US9522914, B-08)
Affinity DataIC50: 2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260341(US9522914, D-30)
Affinity DataIC50: 2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260255(US9522914, B-08)
Affinity DataIC50: 2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260341(US9522914, D-30)
Affinity DataIC50: 2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260342(US9522914, D-31)
Affinity DataIC50: 2.90nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260342(US9522914, D-31)
Affinity DataIC50: 2.90nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM50338810(N-isopropyl-2-(2-(3-methoxyphenyl)-4-oxo-6-(3-(pip...)
Affinity DataIC50: 3nMAssay Description:Displacement of [3H]AVP from human V1b receptor expressed in CHO cells co-expressing VIP-luciferase by whole cell binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM50338810(N-isopropyl-2-(2-(3-methoxyphenyl)-4-oxo-6-(3-(pip...)
Affinity DataIC50: 3nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by whole cell binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260219(US9522914, A-21)
Affinity DataIC50: 3.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260219(US9522914, A-21)
Affinity DataIC50: 3.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260253(US9522914, B-06)
Affinity DataIC50: 3.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260334(US9522914, D-23)
Affinity DataIC50: 3.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260345(US9522914, D-34)
Affinity DataIC50: 3.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260253(US9522914, B-06)
Affinity DataIC50: 3.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 606 total ) | Next | Last >>
Jump to: